University of Pretoria is making its way to a big breakthrough in cancer therapy. They are the only platform in Africa, and one of only three in the world, to offer this treatment.
A possible breakthrough in the treatment of cancer is recorded, following a joint effort between two research bodies, Pretoria Rekord East reports.
The department of nuclear medicine at University of Pretoria and the European Commission’s science and knowledge’s, joint research centre (JRC) used targeted alpha therapy (TAT) to treat advanced-stage prostate cancer with promising results.
“Were it not for this collaboration, the department would not have been able to treat its patients with this form of therapy. TAT has proved to be very successful, with an 85% success rate,” said professor Mike Sathekge, head of nuclear medicine.
TAT is expensive and there are strict international security standards regarding nuclear safety. The two centres are the only ones in Africa, and of only three in the world, to offer this treatment.
The Steve Biko Academic Hospital is the site for the treatment in South Africa.